Literature DB >> 20223198

MicroRNA-mediated control of oligodendrocyte differentiation.

Xianghui Zhao1, Xuelian He, Xiaolei Han, Yang Yu, Feng Ye, Ying Chen, ThaoNguyen Hoang, Xiaomei Xu, Qing-Sheng Mi, Mei Xin, Fan Wang, Bruce Appel, Q Richard Lu.   

Abstract

MicroRNAs (miRNAs) regulate various biological processes, but evidence for miRNAs that control the differentiation program of specific neural cell types has been elusive. To determine the role of miRNAs in the formation of myelinating oligodendrocytes, we selectively deleted a miRNA-processing enzyme, Dicer1, in oligodendrocyte lineage cells. Mice lacking Dicer1 display severe myelinating deficits despite an expansion of the oligodendrocyte progenitor pool. To search for miRNAs responsible for the induction of oligodendrocyte maturation, we identified miR-219 and miR-338 as oligodendrocyte-specific miRNAs in spinal cord. Overexpression of these miRNAs is sufficient to promote oligodendrocyte differentiation. Additionally, blockage of these miRNA activities in oligodendrocyte precursor culture and knockdown of miR-219 in zebrafish inhibit oligodendrocyte maturation. miR-219 and miR-338 function in part by directly repressing negative regulators of oligodendrocyte differentiation, including transcription factors Sox6 and Hes5. These findings illustrate that miRNAs are important regulators of oligodendrocyte differentiation, providing new targets for myelin repair. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223198      PMCID: PMC2855245          DOI: 10.1016/j.neuron.2010.02.018

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  47 in total

Review 1.  Regulation of oligodendrocyte development in the vertebrate CNS.

Authors:  Robert H Miller
Journal:  Prog Neurobiol       Date:  2002-08       Impact factor: 11.685

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  Neural cell fate analysis in zebrafish using olig2 BAC transgenics.

Authors:  Jimann Shin; Hae-Chul Park; Jolanta M Topczewska; David J Mawdsley; Bruce Appel
Journal:  Methods Cell Sci       Date:  2003

Review 4.  Common logic of transcription factor and microRNA action.

Authors:  Oliver Hobert
Journal:  Trends Biochem Sci       Date:  2004-09       Impact factor: 13.807

Review 5.  Glial specification in the vertebrate neural tube.

Authors:  David H Rowitch
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

6.  Axonal transection in the lesions of multiple sclerosis.

Authors:  B D Trapp; J Peterson; R M Ransohoff; R Rudick; S Mörk; L Bö
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

7.  Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein.

Authors:  J E Lee; S M Hollenberg; L Snider; D L Turner; N Lipnick; H Weintraub
Journal:  Science       Date:  1995-05-12       Impact factor: 47.728

8.  Notch receptor activation inhibits oligodendrocyte differentiation.

Authors:  S Wang; A D Sdrulla; G diSibio; G Bush; D Nofziger; C Hicks; G Weinmaster; B A Barres
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

9.  IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes.

Authors:  Jenny Hsieh; James B Aimone; Brian K Kaspar; Tomoko Kuwabara; Kinichi Nakashima; Fred H Gage
Journal:  J Cell Biol       Date:  2004-01-05       Impact factor: 10.539

10.  Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation.

Authors:  S L Pfaff; M Mendelsohn; C L Stewart; T Edlund; T M Jessell
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

View more
  218 in total

1.  Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration.

Authors:  Jifang Tao; Hao Wu; Quan Lin; Weizheng Wei; Xiao-Hong Lu; Jeffrey P Cantle; Yan Ao; Richard W Olsen; X William Yang; Istvan Mody; Michael V Sofroniew; Yi E Sun
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  Tcf7l2 is tightly controlled during myelin formation.

Authors:  Hui Fu; Santosh Kesari; Jun Cai
Journal:  Cell Mol Neurobiol       Date:  2011-12-13       Impact factor: 5.046

Review 3.  Adult-onset autosomal dominant leukodystrophy: linking nuclear envelope to myelin.

Authors:  Shu-Ting Lin; Louis J Ptácek; Ying-Hui Fu
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

Review 4.  MicroRNAs: novel regulators of oligodendrocyte differentiation and potential therapeutic targets in demyelination-related diseases.

Authors:  Jia-Su Li; Zhong-Xiang Yao
Journal:  Mol Neurobiol       Date:  2012-01-05       Impact factor: 5.590

5.  Developmental regulation of microRNA expression in Schwann cells.

Authors:  Nolan G Gokey; Rajini Srinivasan; Camila Lopez-Anido; Courtney Krueger; John Svaren
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

Review 6.  Functions of noncoding RNAs in neural development and neurological diseases.

Authors:  Shan Bian; Tao Sun
Journal:  Mol Neurobiol       Date:  2011-10-04       Impact factor: 5.590

Review 7.  The emerging role of microRNAs in multiple sclerosis.

Authors:  Andreas Junker; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2010-12-14       Impact factor: 42.937

8.  Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy.

Authors:  Taeyeon Kim; Elvira Valera; Paula Desplats
Journal:  Mol Neurobiol       Date:  2019-04-09       Impact factor: 5.590

9.  What are exosomes and how can they be used in multiple sclerosis therapy?

Authors:  Aya D Pusic; Kae M Pusic; Richard P Kraig
Journal:  Expert Rev Neurother       Date:  2014-02-19       Impact factor: 4.618

10.  Coordinated control of oligodendrocyte development by extrinsic and intrinsic signaling cues.

Authors:  Li He; Q Richard Lu
Journal:  Neurosci Bull       Date:  2013-03-13       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.